Market Movers | Bloom Energy Rises on Pelosi Buy; Nebius, NetEase Gain on Goldman Calls; Moderna Rallies

Tiger Newspress
53 mins ago

Moderna rose 10.1% in pre-market trading. The stock remains in a volatile price discovery phase following the historic 177% single-day surge triggered by its mRNA cancer vaccine Phase III trial success.

NetEase shares rose 4.2% in morning trading. Goldman Sachs analyst Lincoln Kong maintained a Buy rating on NetEase and set a price target of $168.

Bloom Energy shares gained 3.5% in morning trading. The filing, signed by Pelosi on Aug. 21, showed purchases of 15,000 shares of Bloom Energy and 200 call options. The energy stock has emerged as a beneficiary of the AI-driven surge in demand for power.

Nebius shares rose 3.3% in morning trading after Goldman Sachs raised target price. Goldman Sachs raised its price target for Nebius to $328 from $286 and maintained a Buy rating.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10